Insights On Trial Design
-
Antibody Drug Conjugates: Global Trial Landscape - Focus On Asia Pacific
5/9/2023
Gain a better understanding of the global clinical trial landscape of antibody drug conjugates (ADCs) and their trends in the Asia Pacific.
-
An Exploration Of ICIs In Cancer Therapy
1/31/2024
This collection of frequently asked questions highlights the remarkable efficacy of immune checkpoint inhibitors (ICIs) and the projected growth of the global ICI market.
-
UK Clinical Trials & Participant Payments: Experience From Across All Phases Of Research
2/15/2023
Read about the relationship between patient engagement and payments, and how this relationship has changed over time.
-
Evolution Of Clinical Trials In The Asia Pacific Region
9/22/2022
With changing global clinical trials landscape, explore how APAC is emerging as the hot spot for conducting clinical trials, especially in China.
-
Audit Trails: Demonstrating TMF Oversight, Completeness, & Accuracy
5/4/2023
Listen in as experts share their knowledge and experience to provide insights on leveraging audit trails for oversight, completeness, and accuracy of TMF management systems.
-
The Emerging Role Of Medical Science Liaisons On Medical Affairs Teams
3/1/2023
Read why more teams are turning to MSLs to effectively facilitate communication between physicians and pharmaceutical companies.
-
Healthcare System Maintains Compliance Via Internal Program Assessment
5/17/2023
After conducting a clinical research operations assessment, see how healthcare administrators were able to ensure compliance and maintain critical funding sources.
-
How To Double High-Performing Site Count In A Priority Indication
3/13/2023
A top 10 biopharmaceutical company wanted to expand its site list in a priority indication and better understand how existing sites in their database performed. Find out what happened next.
-
What Sponsors Need To Know About Medicare Coverage Analysis
8/28/2023
Discover ways to bridge the gap between sites and sponsors regarding the Medicare Coverage Analysis (MCA) for industry-sponsored trials to better align expectations on both sides and avoid frustration.
-
The State Of Rare Disease Clinical Trials
4/19/2023
Gain insight from the challenges, recent progress, and clinical trial needs in the rare disease sector and how technologies and supporting procedures will determine how quickly and effectively new medications can get to market.